Author: Saeed, Abdullah F. U. H.; Wang, Rongzhi; Ling, Sumei; Wang, Shihua
Title: Antibody Engineering for Pursuing a Healthier Future Document date: 2017_3_28
ID: 0fegsm1v_108
Snippet: Similarly, new opportunities have been created by the development of antibody-drug conjugates (ADCs) to treat the infectious diseases or target cancer cells. ADCs are being developed by progressing in antibody generation, selection of exceedingly cytotoxic molecules, and construction of stable linkers that can be investigated in clinical trials (Vincent and Zurini, 2012) . Cytotoxic therapeutic mAbs often help target cell-killing by eliciting imm.....
Document: Similarly, new opportunities have been created by the development of antibody-drug conjugates (ADCs) to treat the infectious diseases or target cancer cells. ADCs are being developed by progressing in antibody generation, selection of exceedingly cytotoxic molecules, and construction of stable linkers that can be investigated in clinical trials (Vincent and Zurini, 2012) . Cytotoxic therapeutic mAbs often help target cell-killing by eliciting immune effector functions. These include antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP) mediated by innate immune effector cells, and complementdependent cytotoxicity (CDC) mediated by humoral components (Figure 6) . in vitro studies, Fc engineering methods have been specifically designed to modulate ADCC, ADCP, and CDC envisioned for therapeutic mediation (Kinder et al., 2015) .
Search related documents:
Co phrase search for related documents- adcp antibody dependent cellular phagocytosis and antibody generation: 1, 2
- adcp antibody dependent cellular phagocytosis and cellular phagocytosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adcp antibody dependent cellular phagocytosis and clinical trial: 1
- ADCs antibody drug conjugate and antibody drug: 1
- ADCs antibody drug conjugate and antibody drug conjugate: 1
- antibody dependent cellular phagocytosis and cellular phagocytosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- antibody drug and cancer cell: 1, 2, 3, 4, 5, 6, 7, 8
- antibody drug and cancer cell target: 1
- antibody drug and cell killing: 1, 2, 3
- antibody drug conjugate and cancer cell: 1, 2
- antibody drug conjugate and cell killing: 1
- antibody generation and cancer cell: 1
- antibody generation and cell killing: 1
- antibody generation and cellular phagocytosis: 1, 2
- cancer cell and cell killing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- cancer cell and cell killing target: 1
- cancer cell and cell mediate: 1, 2, 3, 4, 5, 6, 7, 8
- cancer cell and cell mediate cytotoxicity: 1
- cancer cell and cellular phagocytosis: 1
Co phrase search for related documents, hyperlinks ordered by date